Peptide consultation
A telehealth consultation with a licensed provider is advertised to discuss goals and possible peptide protocols.
View provider source
Virtual provider · Telehealth available
Provider overview
Ways2Well's current support page describes its clinical-review and consultation program as fully digital and lists 45 covered jurisdictions. The company's About page also describes separate Austin and Houston clinics, but because the support page says clinical consults are telehealth-only, this directory profile records the platform's remote care model and does not treat those facilities as general consultation locations. Peptide availability is state- and product-specific.
At a glance
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Services advertised on the provider’s public website, organized by area of care.
A telehealth consultation with a licensed provider is advertised to discuss goals and possible peptide protocols.
View provider sourceThe provider lists this category without establishing which compounds are available in every state.
View provider sourceSleep is listed as a peptide-program category subject to clinician review and state-specific availability.
View provider sourceRecovery-focused peptide consultations are advertised; the directory does not adopt performance or recovery claims.
View provider sourceWays2Well names this category while noting that availability varies by state and product.
View provider sourceThe provider advertises a metabolic and weight-focused peptide category with state and product restrictions.
View provider sourceThe platform advertises broad biomarker panels followed by clinician-prepared reports and optional consultations.
View provider sourceThe provider describes app-based results, remote clinical review, and telehealth follow-up.
View provider sourceHormone-focused recommendations may be included after biomarker review and a provider consultation.
View provider sourceEvidence
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
Supports: identity and programs · Checked Jul 24, 2026
Supports: telehealth model phone states served and labs · Checked Jul 24, 2026
Supports: peptide categories and restrictions · Checked Jul 24, 2026
Supports: peptide consultation and covered states · Checked Jul 24, 2026
Supports: clinical team and company identity · Checked Jul 24, 2026
Supports: bloodwork and membership process · Checked Jul 24, 2026